Skip to content

James Gibson, MD

NPI 1023121159ActiveIndividual· Medical Genetics, Clinical Biochemical Genetics· Austin, TX

Medical Genetics, Clinical Biochemical Genetics (MD) in Austin, Texas, trained at Duke University School of Medicine (class of 1988). Part D covered 92 prescriptions written in 2024, 54% of them generic. Zevra Therapeutics Inc was the largest of 2 companies reporting payments in 2025, $154.95 in all, mostly food and beverage.

Overview

NPI1023121159
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedAug 15, 2006
Last updated in NPPESJan 10, 2012

Specialties and licenses

TaxonomyCodeLicenseState
Medical Genetics, Clinical Biochemical Genetics Primary207SG0202XM7211TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pediatric Medicine (TX)

Part D prescriptions in 2024

Prescriptions (claims)92 · 94 30-day fills
Total drug cost$2,192,095
Generic share54% of claims

Medicare sources and data years

Education and affiliations

Medical schoolDuke University School of Medicine
Graduation year1988
Medicare specialtyPediatric Medicine

Medical group

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$154.95 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Zevra Therapeutics Inc$132.291
Eton Pharmaceuticals, Inc.$22.661

What the 2025 payments were for

  • Food and Beverage$154.95 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records